Cite
HARVARD Citation
Harvey, K. et al. (n.d.). Oncotype DX TM predicts benefit from adjuvant chemotherapy in women with early breast cancer at intermediate risk of distant recurrence. European journal of surgical oncology. 43 (5), pp. S61-S62. [Online].